Announcements Trials

Browse Landscape

Status

Recruiting 4 Withdrawn 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Desmoid Tumors 1

Interventions

pembrolizumab 5 Radiotherapy 4 Radiation 4 ALT-803 4 fludarabine 3 Prednisone 3 Etoposide 3 Cytarabine 3 Cyclophosphamide 3 Cisplatin 3 sacituzumab govitecan 2 daratumumab 2 atezolizumab 2 Vincristine 2 Temozolomide 2 Surveys and Questionnaires 2 Specimen Handling 2 Nivolumab 2 Magnetic Resonance Spectroscopy 2 Lenalidomide 2 Irinotecan 2 Gemcitabine 2 Doxorubicin 2 Biopsy 2 Bevacizumab 2 Androgen Antagonists 2 130-nm albumin-bound paclitaxel 2 zimberelimab 1 vocimagene amiretrorepvec 1 toripalimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Bleomycin × 90 days × Clear all

NCT06660121 2026-05-14

ECT-DESMO

Istituto Ortopedico Rizzoli

Desmoid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡